Covid-19: US regulator raises “significant concerns” over safety of rapid lateral flow tests

The US Food and Drug Agency (FDA) has raised concerns about the safety and the marketing of rapid lateral flow covid-19 tests, which are the cornerstone of the UK’s mass testing programme.On 10…


Read Original Article: Covid-19: US regulator raises “significant concerns” over safety of rapid lateral flow tests »